2

Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in NSCLC

Revisiting a null hypothesis: exploring the parameters of oligometastasis treatment

A Multi-Outcome Meta-Analysis Method Reveals the Genomic Adjusted Radiation Dose is a Continuous Predictive Biomarker of Radiation Outcome

GARD is a pan-cancer predictor of clinical outcome in radiation treated patients.

Identifying States of Collateral Sensitivity during the Evolution of Therapeutic Resistance in Ewing's Sarcoma

UV sterilization of personal protective equipment with idle laboratory biosafety cabinets during the Covid-19 pandemic

Network potential identifies therapeutic miRNA cocktails in Ewings Sarcoma

Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV)

The Acquisition and Analysis of Electroencephalogram Data for the Classification of Benign Partial Epilepsy of Childhood with Centrotemporal Spikes